Gero

Singapore, Singapore

Gero is a biotechnology company that provides therapeutics against chronic diseases.

$6.0M raised

Oct 2023

Series A

Top Investors

VitaDAOBulba VenturesMelnichek InvestmentsLeo Lozner

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Gero raised?

Gero has raised $6.0M in total funding. The most recent round was Series A. The last funding was announced in October 2023.

Who are Gero's investors?

Gero's investors include VitaDAO, Bulba Ventures, Melnichek Investments, Leo Lozner.

Where is Gero headquartered?

Gero is headquartered in Singapore, Singapore.

What does Gero do?

Gero is a biotechnology company that provides therapeutics against chronic diseases.

What stage is Gero at?

Gero is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 18, 2023.

MLA

"Gero — Funding & Investors." VCBacked, October 18, 2023, https://www.vcbacked.co/company/gero. Accessed June 4, 2026.

APA

VCBacked. (2023). Gero — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/gero

Wikipedia (cite web)

{{cite web |title=Gero — Funding & Investors |url=https://www.vcbacked.co/company/gero |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 18, 2023.